Kdac Chem planning to set up Active Pharmaceutical Manufacturing Project in Gujarat

Kdac Chem Private limited is an Indian pharmaceutical corporation headquartered in Gujarat. In Nandesari, Vadodara, the company intends to construct a new active pharmaceutical ingredients (API) plant. The plant will produce APIs for a variety of medications, including antibiotics, anti-cancer drugs, and anti-diabetes drugs, at a rate of one thousand tons per year. The plant, expected to be completed in 2025 at a cost of 61 billion rupees, will generate approximately 500 employment. 

The enterprise is financed through a combination of debt and equity. A consortium of banks is providing the debt financing, whereas Kdac Chem Priva and its investors are providing the equity financing. The initiative is anticipated to have a substantial effect on the regional economy. It is anticipated to create jobs, increase investment, and attract additional pharmaceutical companies to the region. The initiative is also anticipated to have positive environmental effects. 

The facility will utilize sustainable technologies and be devoted to minimizing its environmental impact. The Kdac Chem Priva API facility is a significant investment for the Indian pharmaceutical industry. It demonstrates the increasing confidence in the Indian pharmaceutical industry and the market's potential. Here are some of the benefits of the project: It will create jobs and boost the local economy. It will attract other pharmaceutical companies to the region. It will help to reduce India's dependence on imported APIs. It will help to improve the quality of APIs produced in India. It will help to make India a global leader in the pharmaceutical industry.

As of September 2023, The project is currently in the stage of being approved currently awaiting approval from the government.

News by Rahul Yeligetti